Theravance - THRX Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theravance - THRX

THRX 9.810

+0.4%

Jan 8 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (29)	8/23/2006 9:01:54 AM
From: kenhott	Read Replies (1) of 74

I was just thinking off the top of my head that these trials are a combo of both Non-Inf and Superior so the superior hurdle should be lower than .05 because it was a 2 shots in 1 trials. I was surprise to see the vanco rate of effectiveness given all the news about MRSA. This has to be one of the largest MRSA trials and because it is so recent it provides a good picture about what is going on right now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next